Cargando…
Noninvasive Assessment of Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
Nonalcoholic fatty liver disease (NAFLD) is prevalent in 20–25% of the general population and is associated with metabolic risk factors such as obesity, diabetes mellitus, and dyslipidemia. Histologically, NAFLD ranges from simple steatosis to nonalcoholic steatohepatitis (NASH), fibrosis, and cirrh...
Autores principales: | Buzzetti, Elena, Lombardi, Rosa, De Luca, Laura, Tsochatzis, Emmanuel A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4430647/ https://www.ncbi.nlm.nih.gov/pubmed/26064107 http://dx.doi.org/10.1155/2015/343828 |
Ejemplares similares
-
Advances in Noninvasive Biomarkers for Nonalcoholic Fatty Liver Disease
por: Gîlcă-Blanariu, Georgiana-Emmanuela, et al.
Publicado: (2023) -
Noninvasive imaging biomarkers for liver fibrosis in nonalcoholic fatty liver disease: current and future
por: Yu, Jung Hwan, et al.
Publicado: (2023) -
Noninvasive assessment of fibrosis among patients with nonalcoholic fatty liver disease [NAFLD]
por: Bernstein, David, et al.
Publicado: (2022) -
Liver test abnormalities in patients with HIV mono-infection: assessment with simple noninvasive fibrosis markers
por: Lombardi, Rosa, et al.
Publicado: (2017) -
Noninvasive Evaluation of Nonalcoholic Fatty Liver Disease
por: Lee, Dae Ho
Publicado: (2020)